These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 12528002)
1. Loss of color vision during long-term treatment with pramipexole. Müller T; Przuntek H; Kuhlmann A J Neurol; 2003 Jan; 250(1):101-2. PubMed ID: 12528002 [No Abstract] [Full Text] [Related]
2. Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. Mizuno Y; Yanagisawa N; Kuno S; Yamamoto M; Hasegawa K; Origasa H; Kowa H; Mov Disord; 2003 Oct; 18(10):1149-56. PubMed ID: 14534919 [TBL] [Abstract][Full Text] [Related]
3. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test. Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263 [TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial. Möller JC; Oertel WH; Köster J; Pezzoli G; Provinciali L Mov Disord; 2005 May; 20(5):602-10. PubMed ID: 15726540 [TBL] [Abstract][Full Text] [Related]
12. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211 [TBL] [Abstract][Full Text] [Related]
14. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
15. Sleep episodes in Parkinson's disease: a wake-up call. Frucht SJ; Greene PE; Fahn S Mov Disord; 2000 Jul; 15(4):601-3. PubMed ID: 10928569 [No Abstract] [Full Text] [Related]
16. Modafinil treatment of pramipexole-associated somnolence. Hauser RA; Wahba MN; Zesiewicz TA; McDowell Anderson W Mov Disord; 2000 Nov; 15(6):1269-71. PubMed ID: 11104221 [No Abstract] [Full Text] [Related]
17. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A; Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734 [TBL] [Abstract][Full Text] [Related]
18. [Pathological gambling associated with pramipexole use in Parkinson's disease]. Lester J; Gonzalez-Aleman G; Zuniga-Ramirez C; Diaz-Pascuali SP; Raina-Castellino GB; Micheli-Gould F Rev Neurol; 2006 Sep 1-15; 43(5):316-8. PubMed ID: 16941434 [No Abstract] [Full Text] [Related]
19. Weight loss is often a problem in late PD. Jacques C; Davies R; Friedman JH J Neurosci Nurs; 1998 Dec; 30(6):342. PubMed ID: 9949971 [No Abstract] [Full Text] [Related]
20. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease. Katz KA; Cotsarelis G; Gupta R; Seykora JT J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S103-4. PubMed ID: 17052518 [No Abstract] [Full Text] [Related] [Next] [New Search]